Sterling Visiting Professorship

Louis Lasagna

Louis Lasagna, MD

The Sterling Drug Company established a Visiting Professorship in honor of the late Dr Louis Lasagna, Professor of Pharmacology and former Dean of the Sackler School of Graduate Biomedical Sciences. Often referred to as "the father of Clinical Pharmacology", Dr Lasagna started the first academic division of Clinical Pharmacology at Johns Hopkins University School of Medicine in 1954. He trained leaders in this field from the United States and many foreign countries and his scientific publications number in the hundreds.

The Sterling Company's Visiting Professor Program is designed to promote an interchange of knowledge about pharmacology among institutions of higher learning because pharmacology is the keystone in the development of new, safe and effective medicines. The Program in Pharmacology & Experimental Therapeutics invites a Visiting Professor annually to present major lectures and conduct workshops with staff, students and guests.

Recent Sterling Visiting Professors include:

  • 2012 - Mark Fishman, MD, Novartis Institutes for Biomedical Research 
  • 2009 - Paul Watkins, MD, University of North Carolina - Chapel Hill
  • 2008 - Bruce Spiegelman, PhD, Harvard Medical School
  • 2007 - Nora Volkow, MD, NIDA
  • 2006 - Barbara Corkey, PhD, Boston University School of Medicine
  • 2005 - Paul Needleman, PhD, Prospect Venture Partners
  • 2004 - Robert Temple, MD, FDA
  • 2003 - Jerome Groopman, MD, Harvard Medical School
  • 2002 - Tomas Hokfelt, MD, PhD, Karolinska Institute 
  • 2001 - Eric Lander, PhD, MIT


Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development

June 15: Online Certificate in Fundamentals of Clinical Care Research